Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$359,829
+$83,898 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#4,025
of 4,605 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbus Macro, LLC holds $32,705,466 across 7 Drug Manufacturers - General names. LLY ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
35,867 | $9,109,141 | |
| 2 | ABBV |
AbbVie Inc.
|
30,821 | $7,755,796 | |
| 3 | AMGN |
Amgen Inc
|
20,153 | $7,297,804 | |
| 4 | AZN |
Astrazeneca PLC
|
15,923 | $3,019,319 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,700 | $2,741,578 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,034 | $2,421,999 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
300 | $359,829 |
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,829 | 300 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $275,931 | 300 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $322,404 | 300 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $228,900 | 300 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $233,859 | 300 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $247,773 | 300 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $231,600 | 300 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $265,782 | 300 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $271,614 | 300 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $233,388 | 300 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $229,670 | 394 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $211,629 | 394 | Shares | Sole | 2023-10-16 | |
| No filing history on record for this holder in this stock. | ||||||